1224 related articles for article (PubMed ID: 18087627)
1. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
[TBL] [Abstract][Full Text] [Related]
3. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of nosocomial isolates against a new aminoglycoside isepamicin.
Kapil A; Bali R; Das BK
Indian J Med Res; 2001 Feb; 113():60-2. PubMed ID: 21910285
[TBL] [Abstract][Full Text] [Related]
5. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
6. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
7. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.
J Chemother; 1995 Jun; 7 Suppl 2():17-30. PubMed ID: 8622108
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
Sader HS; Jones RN; Stilwell MG; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):181-6. PubMed ID: 16105562
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
10. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
11. Invitro comparative evaluation of aminoglycosides at a cancer centre.
Biswas SK; Kelkar RS
Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Gram-negative bacterial pathogens in bloodstream infections and their resistance to antibiotics in the Czech Republic.
Cermák P; Kolár M; Látal T
Int J Antimicrob Agents; 2004 Apr; 23(4):401-4. PubMed ID: 15081092
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens].
Gür D; Kocagöz T; Akalin HE
Mikrobiyol Bul; 1992 Jul; 26(3):233-41. PubMed ID: 1528143
[TBL] [Abstract][Full Text] [Related]
14. Preclinical comparative evaluation of aminoglycosides.
Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of isepamicin and other antibiotics against gram-negative bacilli from intensive care units (ICU) in Belgium.
Belgian Isepamicin Multicenter Study Group
Acta Clin Belg; 2001; 56(5):307-15. PubMed ID: 11774843
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006.
Chen WY; Jang TN; Huang CH; Hsueh PR
J Microbiol Immunol Infect; 2009 Aug; 42(4):317-23. PubMed ID: 19949755
[TBL] [Abstract][Full Text] [Related]
17. Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
Dong SX; Wang JT; Chang SC
J Microbiol Immunol Infect; 2012 Dec; 45(6):459-64. PubMed ID: 23102796
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
19. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
Saghir S; Faiz M; Saleem M; Younus A; Aziz H
Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
[TBL] [Abstract][Full Text] [Related]
20. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
